ALT Competitors & Alternatives
Compare Altimmune Inc with similar stocks in the same industry
Biotechnology
ALT
Main Stock$2.91
Tradestie Score
59
Market Cap
$341.56M
Revenue Growth
4.2%
Analyst Upside
+430.9%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$11.81
|
$665.30M | - | 57 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$15.07
|
$626.91M | - | 60 | Compare |
|
SVRA
Savara Inc.
|
$5.78
|
$611.84M | - | 66 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.15
|
$552.46M | - | 57 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.63
|
$540.97M | - | 54 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.00
|
$529.35M | 6.3 | 64 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.16
|
$512.39M | - | 57 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$35.61
|
$505.12M | 1.9 | 64 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$92.91
|
$492.21M | - | 53 | Compare |
More ALT Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry